24 August 2015Americas
US court invalidates Velcade patent after Sandoz challenge
Sandoz, Allergan and Accord Healthcare have demonstrated “clear and convincing” evidence that a patent owned by Millennium Pharmaceuticals and used in its Velcade (bortezomib) cancer treatment drug is invalid, according to a US court ruling.
